NCT07760727
High-Flow Nasal Oxygyen Therapy During Sedated Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration(EBUS-TBNA)
StatusCompleted
PhaseNot specified
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 6 words Show 4 more changesShow less
- Completed without a posted recruiting period
- Study completion date changed from estimate of Nov 20, 2026 to Oct 20, 2026
- Site contact updated
- Publications: details revised at 1 of 1 entry
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Respiratory Complications
Timeframe: During the procedure
Secondary (5)
Oxygen partial pressure (PaO2)
Carbon dioxide partial pressure (PvCO2)
Venous pH
Venous Oxygen Saturation (SvO2)
Recovry Time
Arms and interventions
Group H (High-Flow Nasal Oxygen Group)
Patients undergoing sedated EBUS-TBNA who receive high-flow nasal oxygen therapy during the procedure. Respiratory complications, oxygenation parameters, blood gas values, and post-procedural recovery outcomes are evaluated.
Group C (Conventional Oxygen Group)
Patients undergoing sedated EBUS-TBNA who receive conventional oxygen therapy during the procedure. Respiratory complications, oxygenation parameters, blood gas values, and post-procedural recovery outcomes are evaluated.
Devices: High-Flow Nasal Oxygen Therapy, Conventional Oxygen Therapy
Sites
1 site in 1 country
- Ankara Dr. Abdurrahman Yurtaslan Oncolgy Training and Research HospitalAnkara, Central, Turkey (Türkiye)